Viatris (VTRS) Enterprise Value Growth (1y) (2020 - 2026)
Viatris (VTRS) Enterprise Value Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.31 Bn | 39.66 Bn | 2.15 Bn |
| 3 | Zoetis | 31.65 Bn | 29.98 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.18 Bn | 19.52 Bn | 683.80 Mn |
| 6 | Viatris | 18.82 Bn | 17.94 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.70 Bn | 15.31 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Alkermes | 8.21 Bn | 7.55 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -56.51% |
| Mar 31, 2026 | -138.97% |
| Dec 31, 2025 | -79.65% |
| Sep 30, 2025 | 48.09% |
| Jun 30, 2025 | 38.25% |
| Mar 31, 2025 | 25.59% |
| Dec 31, 2024 | 25.79% |
| Sep 30, 2024 | -43.46% |
| Jun 30, 2024 | -45.77% |
| Mar 31, 2024 | -100.28% |
| Dec 31, 2023 | 21.43% |
| Sep 30, 2023 | -102.51% |
| Jun 30, 2023 | 5.34% |
| Mar 31, 2023 | 32.67% |
| Dec 31, 2022 | -78.77% |
| Sep 30, 2022 | 14.53% |
| Jun 30, 2022 | 1.37% |
| Mar 31, 2022 | 6.75% |
| Dec 31, 2021 | 16.92% |
| Sep 30, 2021 | 93.36% |